Morgan Stanley analyst Nigel Dally maintains Jackson Finl (NYSE:JXN) with a Equal-Weight and lowers the price target from $33 to $31.
Psychedelics Company Conducts Investigation Into Potential Naked Short Selling Of Its Stock
FSD Pharma Inc. (NASDAQ: HUGE) has renewed a service agreement with shareholder intelligence services provider ShareIntel LLC to assist in ongoing